Investments
42Portfolio Exits
2About Guofang Investment
Guofang Investment is an FoF subsidiary of Shanghai International Group that focuses on funds investing in biopharmaceutical, fintech, business services, healthcare, and more.
Guofang Investment Investments
42 Investments
Guofang Investment has made 42 investments. Their latest investment was in Genepoint Biological Technology as part of their Series D on January 1, 2023.
Guofang Investment Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/18/2023 | Series D | Genepoint Biological Technology | $29.6M | Yes | 2 | |
12/30/2022 | Series D | QCC.com | Yes | |||
12/28/2022 | Series B | Linggas | Yes | 1 | ||
12/7/2022 | Series C - II | |||||
10/20/2022 | Series B |
Date | 1/18/2023 | 12/30/2022 | 12/28/2022 | 12/7/2022 | 10/20/2022 |
|---|---|---|---|---|---|
Round | Series D | Series D | Series B | Series C - II | Series B |
Company | Genepoint Biological Technology | QCC.com | Linggas | ||
Amount | $29.6M | ||||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 1 |
Guofang Investment Portfolio Exits
2 Portfolio Exits
Guofang Investment has 2 portfolio exits. Their latest portfolio exit was MGI Tech on September 09, 2022.
Loading...